Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia

References

• Abkowitz JL, Chen J. 2007. Studies of c-Mpl function distinguish the replication of hematopoietic stem cells from the expansion of differentiating clones. Blood 109:5186–5190
   PubMed Web of Science ®Google Scholar
• Alexander WS, Roberts AW, Nicola NA, Li R, Metcalf D. 1996. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood 87:2162–2170
   PubMed Web of Science ®Google Scholar
• Ballmaier M, Germeshausen M, Schulze H, Cherkaoui K, Lang S, Gaudig A, Krukemeier S, et al. 2001. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Blood 97:139–146
   PubMed Web of Science ®Google Scholar
• Bass SH, Mulkerrin MG, Wells JA. 1991. A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor. Proc Natl Acad Sci USA 88:4498–4502
   PubMedGoogle Scholar
• Bazan JF. 1990. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87:6934–6938
   PubMed Web of Science ®Google Scholar
• Broudy VC, Lin NL, Sabath DF, Papayannopoulou T, Kaushansky K. 1997. Human platelets display high-affinity receptors for thrombopoietin. Blood 89:1896–1904
   PubMed Web of Science ®Google Scholar
• Chen J, Olsen J, Ford S, Mirza S, Walker A, Murphy JM, Young IG. 2009. A new isoform of interleukin-3 receptor {alpha} with novel differentiation activity and high affinity binding mode. J Biol Chem 284:5763–5773
   Google Scholar
• Chung HS, Koh KN, Kim HJ, Lee KO, Park CJ, Chi HS, Kim SH, et al. 2011. A novel nonsense mutation in the MPL gene in congenital amegakaryocytic thrombocytopenia. Pediatr Blood Cancer 56:304–306
   Google Scholar
• Clackson T, Wells JA. 1995. A hot spot of binding energy in a hormone-receptor interface. Science 267:383–386
   PubMed Web of Science ®Google Scholar
• de Vos AM, Ultsch M, Kossiakoff AA. 1992. Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 255:306–312
   PubMed Web of Science ®Google Scholar
• Debili N, Wendling F, Cosman D, Titeux M, Florindo C, Dusanter-Fourt I, Schooley K, et al. 1995a. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood 85:391–401
   PubMed Web of Science ®Google Scholar
• Debili N, Wendling F, Katz A, Guichard J, Breton-Gorius J, Hunt P, Vainchenker W. 1995b. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 86:2516–2525
   PubMed Web of Science ®Google Scholar
• Drachman JG, Griffin JD, Kaushansky K. 1995. The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-Mpl. J Biol Chem 270:4979–4982
   PubMed Web of Science ®Google Scholar
• Fox NE, Chen R, Hitchcock I, Keates-Baleeiro J, Frangoul H, Geddis AE. 2009. Compound heterozygous c-Mpl mutations in a child with congenital amegakaryocytic thrombocytopenia: Functional characterization and a review of the literature. Exp Hematol 37:495–503
   PubMed Web of Science ®Google Scholar
• Fox NE, Lim J, Chen R, Geddis AE. 2010. F104S c-Mpl responds to a transmembrane domain-binding thrombopoietin receptor agonist: Proof of concept that selected receptor mutations in congenital amegakaryocytic thrombocytopenia can be stimulated with alternative thrombopoietic agents. Exp Hematol 38:384–391
   Google Scholar
• Gandhi MJ, Pendergrass TW, Cummings CC, Ihara K, Blau CA, Drachman JG. 2005. Congenital amegakaryocytic thrombocytopenia in three siblings: Molecular analysis of atypical clinical presentation. Exp Hematol 33:1215–1221
   PubMed Web of Science ®Google Scholar
• Germeshausen M, Ballmaier M, Welte K. 2006. MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: The type of mutation predicts the course of the disease. Hum Mutat 27:296
   PubMedGoogle Scholar
• Gluzman Y. 1981. SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23:175–182
   PubMed Web of Science ®Google Scholar
• Hercus TR, Barry EF, Dottore M, McClure BJ, Webb AI, Lopez AF, Young IG, et al. 2013. High yield production of a soluble human interleukin-3 variant from E. coli with wild-type bioactivity and improved radiolabeling properties. PLoS ONE 8:e74376
   PubMedGoogle Scholar
• Hilton DJ, Watowich SS, Katz L, Lodish HF. 1996. Saturation mutagenesis of the WSXWS motif of the erythropoietin receptor. J Biol Chem 271:4699–4708
   PubMed Web of Science ®Google Scholar
• Hobbs S, Jitrapakdee S, Wallace JC. 1998. Development of a bicistronic vector driven by the human polypeptide chain elongation factor 1alpha promoter for creation of stable mammalian cell lines that express very high levels of recombinant proteins. Biochem Biophys Res Commun 252:368–372
   PubMedGoogle Scholar
• Ihara K, Ishii E, Eguchi M, Takada H, Suminoe A, Good RA, Hara T. 1999. Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. Proc Natl Acad Sci USA 96:3132–3136
   PubMed Web of Science ®Google Scholar
• Kimura S, Roberts AW, Metcalf D, Alexander WS. 1998. Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. Proc Natl Acad Sci USA 95:1195–1200
   PubMed Web of Science ®Google Scholar
• Lock P, Metcalf D, Nicola NA. 1994. Histidine-367 of the human common beta chain of the receptor is critical for high-affinity binding of human granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci USA 91:252–256
   PubMed Web of Science ®Google Scholar
• Middleton SA, Barbone FP, Johnson DL, Thurmond RL, You Y, McMahon FJ, Jin R, et al. 1999. Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide. J Biol Chem 274:14163–14169
   PubMed Web of Science ®Google Scholar
• Middleton SA, Johnson DL, Jin R, McMahon FJ, Collins A, Tullai J, Gruninger RH, et al. 1996. Identification of a critical ligand binding determinant of the human erythropoietin receptor. Evidence for common ligand binding motifs in the cytokine receptor family. J Biol Chem 271:14045–14054
   Google Scholar
• Miller J, Malek TR, Leonard WJ, Greene WC, Shevach EM, Germain RN. 1985. Nucleotide sequence and expression of a mouse interleukin 2 receptor cDNA. J Immunol 134:4212–4217
   PubMed Web of Science ®Google Scholar
• Mirza S, Chen J, Wen B, Ewens CL, Dai J, Murphy JM, Young IG. 2010a. Two modes of beta-receptor recognition are mediated by distinct epitopes on mouse and human interleukin-3. J Biol Chem 285:22370–22381
   Google Scholar
• Mirza S, Walker A, Chen J, Murphy J, Young I. 2010b. The Ig-like domain of human GM-CSF receptor α plays a critical role in cytokine binding and receptor activation. Biochem J 426:307–317
   PubMedGoogle Scholar
• Muraoka K, Ishii E, Tsuji K, Yamamoto S, Yamaguchi H, Hara T, Koga H, et al. 1997. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia. Br J Haematol 96:287–292
   PubMed Web of Science ®Google Scholar
• Murphy JM, Ford SC, Olsen JE, Gustin SE, Jeffrey PD, Ollis DL, Young IG. 2004. Interleukin-3 binding to the murine betaIL-3 and human betac receptors involves functional epitopes formed by domains 1 and 4 of different protein chains. J Biol Chem 279:26500–26508
   PubMed Web of Science ®Google Scholar
• Murphy JM, Ford SC, Wiedemann UM, Carr PD, Ollis DL, Young IG. 2003. A novel functional epitope formed by domains 1 and 4 of the human common beta-subunit is involved in receptor activation by granulocyte macrophage colony-stimulating factor and interleukin 5. J Biol Chem 278:10572–10577
   PubMed Web of Science ®Google Scholar
• Murphy JM, Soboleva TA, Mirza S, Ford SC, Olsen JE, Chen J, Young IG. 2008. Clarification of the role of N-glycans on the common beta-subunit of the human IL-3, IL-5 and GM-CSF receptors and the murine IL-3 beta-receptor in ligand-binding and receptor activation. Cytokine 42:234–242
   Google Scholar
• Murphy JM, Young IG. 2006. IL-3, IL-5, and GM-CSF signaling: Crystal structure of the human beta-common receptor. Vitam Horm 74:1–30
   PubMed Web of Science ®Google Scholar
• Palacios R, Steinmetz M. 1985. Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41:727–734
   PubMed Web of Science ®Google Scholar
• Passos-Coelho JL, Sebastiao M, Gameiro P, Reichert A, Vieira L, Ferreira I, Miranda N, et al. 2007. Congenital amegakaryocytic thrombocytopenia – report of a new c-mpl gene missense mutation. Am J Hematol 82:240–241
   Google Scholar
• Pemberton LC, Levett D, Skinner R, Hall AG, Hanley JP. 2006. Novel mutations in a child with congenital amegakaryocytic thrombocytopenia. Br J Haematol 135:742–743
   Google Scholar
• Rost B, Yachdav G, Liu J. 2004. The PredictProtein server. Nucleic Acids Res 32:W321–W326
   PubMed Web of Science ®Google Scholar
• Sabath DF, Kaushansky K, Broudy VC. 1999. Deletion of the extracellular membrane-distal cytokine receptor homology module of Mpl results in constitutive cell growth and loss of thrombopoietin binding. Blood 94:365–367
   PubMed Web of Science ®Google Scholar
• Savoia A, Dufour C, Locatelli F, Noris P, Ambaglio C, Rosti V, Zecca M, et al. 2007. Congenital amegakaryocytic thrombocytopenia: Clinical and biological consequences of five novel mutations. Haematologica 92:1186–1193
   Google Scholar
• Schipper LF, Brand A, Reniers NC, Melief CJ, Willemze R, Fibbe WE. 1998. Effects of thrombopoietin on the proliferation and differentiation of primitive and mature haemopoietic progenitor cells in cord blood. Br J Haematol 101:425–435
   Google Scholar
• Shi J, Blundell TL, Mizuguchi K. 2001. FUGUE: Sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. J Mol Biol 310:243–257
   PubMed Web of Science ®Google Scholar
• Steinberg O, Gilad G, Dgany O, Krasnov T, Zoldan M, Laor R, Kapelushnik J, et al. 2007. Congenital amegakaryocytic thrombocytopenia-3 novel c-MPL mutations and their phenotypic correlations. J Pediatr Hematol Oncol 29:822–825
   Google Scholar
• Stoddart MT, Connor P, Germeshausen M, Ballmaier M, Steward CG. 2013. Congenital amegakaryocytic thrombocytopenia (CAMT) presenting as severe pancytopenia in the first month of life. Pediatr Blood Cancer 60:E94–E96
   Google Scholar
• Syed RS, Reid SW, Li C, Cheetham JC, Aoki KH, Liu B, Zhan H, et al. 1998. Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 395:511–516
   PubMed Web of Science ®Google Scholar
• Tijssen MR, di Summa F, van den Oudenrijn S, Zwaginga JJ, van der Schoot CE, Voermans C, de Haas M. 2008. Functional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congenital amegakaryocytic thrombocytopenia. Br J Haematol 141:808–813
   Google Scholar
• van den Oudenrijn S, Bruin M, Folman CC, Peters M, Faulkner LB, de Haas M, von dem Borne AE. 2000. Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopenia. Br J Haematol 110:441–448
   PubMed Web of Science ®Google Scholar
• Woodcock JM, Zacharakis B, Plaetinck G, Bagley CJ, Qiyu S, Hercus TR, Tavernier J, et al. 1994. Three residues in the common beta chain of the human GM-CSF, IL-3 and IL-5 receptors are essential for GM-CSF and IL-5 but not IL-3 high affinity binding and interact with Glu21 of GM-CSF. EMBO J 13:5176–5185
   PubMed Web of Science ®Google Scholar
• Zhang JL, Simeonowa I, Wang Y, Sebald W. 2002. The high-affinity interaction of human IL-4 and the receptor alpha chain is constituted by two independent binding clusters. J Mol Biol 315:399–407
   PubMed Web of Science ®Google Scholar